As of 2025-05-20, the Fair Value of NervGen Pharma Corp (NGEN.V) is -1.69 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.68 CAD, the upside of NervGen Pharma Corp is -136.01%.
With the market price of 4.68 CAD and our fair value calculation, NervGen Pharma Corp (NGEN.V) is not a good investment. Investing in NGEN.V stocks now will result in a potential loss of 136.01%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -11.19 | -12.73 | -20.72 | -22.38 | -24.01 | -18.20 |
| YoY growth | -14.55% | -13.77% | -62.83% | -8.01% | -7.25% | -21.28% |
| Market Cap (mil) | 333.36 |
| P/E | |
| Forward P/E |
| EPS | -0.34 |
| Avg earnings growth rate | -21.28% |
| TTM earnings | -24.01 |